Seoul, South Korea-based imaging technology developer Brightonix Imaging has received clearance from the U.S. Food and Drug Administration (FDA) for its PHAROS PET scanner.
Brightonix's PHAROS PET scanner.Brightonix
The scanner is multifunctional, with the ability to physically orient the patient seat and detector configurations for extremity and breast imaging, as well as convert to both lying and seated modes for brain imaging. In addition, the scanner was designed with a space-efficient footprint, enabling easier installation in a wide range of clinical environments, Brightonix said. PHAROS features an intuitive interface and a streamlined workflow that makes it easy to operate, the company added.
The development of PHAROS was supported by the Korea Medical Device Development Fund, a collaborative initiative across government ministries, the company noted.
